Company / Revenue per Share
Immix Biopharma, Inc. Revenue per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.73
FY2025
5-year range
$0.73 / $1.44
FY2023-FY2025
Trend
-27.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1.44 to $0.73 over the past 2 years.
Based on SEC 10-K filings.
0.73 in FY2025.
Declined from $1.44 to $0.73 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 27.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.73 | -27.7% |
| FY2024 | $1.00 | -30.3% |
| FY2023 | $1.44 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026